TORSELLO ANTONIO BIAGIO
- U08, Floor: 2, Room: 2011
Publications
Stea, E., Pugliano, M., Gualtierotti, R., Mazzucato, M., Santangelo, L., Annicchiarico, G., et al. (2025). Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): recommendations from Italian scientific societies, patient associations and regulators. PHARMACOLOGICAL RESEARCH, 216(June 2025) [10.1016/j.phrs.2025.107714]. Detail
Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., et al. (2025). Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What
Are the Connections?. CURRENT NEUROPHARMACOLOGY, 23(2), 172-186 [10.2174/1570159x22999240722095039]. DetailMeanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186 [10.1016/j.biopha.2025.118044]. Detail
Ranzani, A., Castelli, F., Di Biagio, A., d'Arminio Monforte, A., D'Avolio, A., Soria, A., et al. (2024). Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects. HIV MEDICINE, 25(4 (April 2024)), 491-497 [10.1111/hiv.13600]. Detail
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Detail